Cited by 94Virus-based gene therapy researchRNA Interference and Gene DeliveryBarrier Structure and Function Studies

A Large U3 Deletion Causes Increased In Vivo Expression from a Nonintegrating Lentiviral Vector

Open access
Bayer, Matthew, Kantor, Boris, Cockrell, Adam, Ma, Hong, Zeithaml, Brian, Li, Xiangping, McCown, Thomas, Kafri, Tal·2008·Molecular Therapy

Abstract

The feasibility of using nonintegrating lentiviral vectors has been demonstrated by recent studies showing their ability to maintain transgene expression both in vitro and in vivo. Furthermore, human immunodeficiency virus-1 (HIV-1) vectors packaged with a mutated integrase were able to correct retinal disease in a mouse model. Interestingly, these results differ from earlier studies in which first-generation nonintegrating lentiviral vectors yielded insignificant levels of transduction. However, to date, a rigorous characterization of transgene expression from the currently used self-inactivating (SIN) nonintegrating lentiviral vectors has not been published. In this study, we characterize transgene expression from SIN nonintegrating lentiviral vectors. Overall, we found that nonintegrating vectors express transgenes at a significantly lower level than their integrating counterparts. Expression from nonintegrating vectors was improved upon introducing a longer deletion in the vector's U3 region. A unique shuttle-vector assay indicated that the relative abundance of the different episomal forms was not altered by the longer U3 deletion. Interestingly, the longer U3 deletion did not enhance expression in the corpus callosum of the rat brain, suggesting that the extent of silencing of episomal transcription is influenced by tissue-specific factors. Finally, and for the first time, episomal expression in the mouse liver was potent and sustained.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mt.2008.199

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Removing cis-acting genes can reduce the use of inhibitors to episomal transgene expression, although this is still insignificant and requires further studies.

    “On the other hand, one can also reduce the use of inhibitors to episomal transgene expression, by removing cis-acting genes, although this is still insignificant [73] and requires further studies.”

    From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [73]

    The Introduction and Results report that deleting more of the U3 region improved episomal transgene expression, and the Discussion calls for further characterization. But the paper describes the improvement as significant, not insignificant; it says expression from nonintegrating vectors remained lower than from integrating vectors. The deleted material is a cis-acting region or sequence, not a gene. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • NILVs encoding for in vivo expression of GFP have been reported in organs such as the brain, liver, and spinal cord via stable gene transfer for up to months.

    “NILVs encoding for in vivo expression of GFP have been reported in organs such as the brain, liver, and spinal cord via stable gene transfer for longer periods (up to months) in several studies [22,73,131,132,133,134].”

    From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [73]

    The Results (page not provided) report GFP expression from nonintegrating vectors in rat brain tissue three months after infusion. They also report largely stable expression in mouse liver for six months, but the liver transgene was luciferase, not GFP. The paper does not report spinal-cord expression. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 51 · Cited by 94

Authors
Bayer, M., Kantor, B., Cockrell, A., Ma, H., Zeithaml, B., Li, X., McCown, T., & Kafri, T.
Affiliations
University of North Carolina at Chapel Hill (US)
Corresponding author
Kafri, Tal
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2008-12
Volume
16
Issue
12
Pages
1968-1976
ISSN
1525-0016 (ISSN-L)
OpenAlex
W2033627909
Cited by
94
References
51
Citations by year
2025: 3 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 6 · 2016: 2 · 2015: 6 · 2014: 8 · 2013: 5 · 2012: 10
FWCI
6.08
Type
journal article
Language
en
Open access
Locations
  • Molecular Therapy (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • UNC Libraries
Funders
  • National Institutes of Health (183-H12-5C, 5r01dk058702-17, DK065988, 5-PO1-HL066973-05, 2-R01-DK058702-06)
  • Center for AIDS Research, University of Washington
  • National Heart, Lung, and Blood Institute (R21HL086406, 5-R21-HL086406, P01HL066973, 5-P01-HL066973-05)
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK058702, 2-R01-DK058702-06, P30DK065988)
  • Center for AIDS Research, University of North Carolina at Chapel Hill
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
self-inactivating vectors, transgene expression, HIV-1 integrase, tissue-specific gene expression, hepatic gene expression, corpus callosum, gene therapy vectors
MeSH terms
Animals, Brain, Cell Line, Genetic Vectors, Humans, Liver, Male, Plasmids, Gene Expression, Lentivirus, Genome, Viral, Gene Deletion, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review